Although the U.S. and Canada reached a preliminary agreement Sunday on a revamped North American trade deal, it will likely be more than a year before it can be enforced. The new trade agreement, dubbed the United States-Mexico-Canada Agreement, revises the North American Free Trade Agreement (NAFTA) to afford 10 years of biologics market protection, extending the eight years of protection that Canada currently offers (see "Canada Agrees to 10 Years Exclusivity for Biologics").
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,